Pulmonary Involvement in the Antiphospholipid Syndrome

Handbook of Systemic Autoimmune Diseases

Volumn 2, Issue , 2004, Pages 137-145

  Espinosa, Gerard ^a   Cervera, Ricard ^a   García Carrasco, Mario ^b   Font, Josep ^b   Asherson, Ronald A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28244488833     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(04)02007-0     Document Type: Review

References (82)

1. Alarcón-Segovia D., and Sánchez-Guerrero J. Primary antiphospholipid syndrome. J. Rheumatol. 16 (1989) 482-488
2. Alarcón-Segovia D., Deleze M., Oria C.V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 68 (1989) 353-365
3. Alarcón-Segovia D., Pérez-Vázquez M.E., Villa A.R., Drenkard C., and Cabiedes J. Preliminary classifcation criteria for the antiphospholipid syndrome within systemic lupus erythematosus. J. Rheumatol. 21 (1992) 275-286
4. Anderson E.N., and Ali M.R. The lupus anticoagulant, pulmonary thromboembolism and fatal pulmonary hypertension. Ann. Rheum. Dis. 43 (1984) 760-763
5. Ando M., Takamoto S., Okita Y., Matsukawa R., Nakanishi N., Kyotani S., et al. Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann. Thorac. Surg. 66 (1998) 1919-1924
6. Argento A., and DiBenedetto R.J. ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome. Chest 113 (1998) 1136-1138
7. Aronoff D.M., and Callen J.P. Necrosing livedo reticularis in a patient with recurrent pulmonary hemorrhage. J. Am. Acad. Dermatol. 37 (1997) 300-302
8. Asherson R.A., Mackworth-Young C.G., Boey M.L., Hull R.G., Saunders A., Gharavi A.E., et al. Pulmonary hypertension in systemic lupus erythematosus. Br. Med. J. 287 (1983) 1024-1025
9. Asherson R.A., Hackett D., Gharavi A.E., Harris E.N., Kennedy H.G., and Hughes G.R.V. Pulmonary hypertension in systemic lupus erythematosus. A report of three cases. J. Rheumatol. 12 (1986) 416-420
10. Asherson R.A., Khamashta M.A., Ordi-Ros J., Derksen R.H.W.M., Machin S.J., Path F.R.C., et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68 (1989) 366-374
11. Asherson R.A., Higenbottam T.W., Dinh Xuan A.T., Khamashta M.A., and Hughes G.R.V. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J. Rheumatol. 17 (1990) 1292-1298
12. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
13. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., and Petri M.A. Catastrophic Antiphospholipid Syndrome. Clues to the Pathogenesis from a Series of 80 Patients. Medicine (Baltimore) 80 (2001) 355-377 These 2 studies describe the prevalence of clinical and immunologic features and the outcome of the first 130 patients with catastrophic APS
14. Atsumi T., Khamashta M.A., Haworth R.S., Brooks G., Amengual O., Ichikawa K., et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role of endothelin-1. Arthritis Rheum. 41 (1998) 800-807 This study shows high levels of endothelin-1 in plasmas of APS patients with arterial thrombosis
15. Auger W.R., Permpikul P., and Moser K.M. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am. J. Med. 99 (1995) 392-396
16. Bayraktar Y., Tanaci N., Egesel T., Gokoz A., and Balkanci F. Antiphospholipid syndrome presenting as portopulmonary hypertension. J. Clin. Gastroenterol. 32 (2001) 359-361
17. Bertoli A.M., Tabares A.H., Casas J.P., Saurit V., Caeiro F., and Alvarellos A. Lung cavitation in primary antiphospholipid syndrome. Lupus 11 (2002) 57-59
18. Branch D.W., Kochenour N.K., Rok N.S., and Scott J.R. A new postpsrtum syndrome associated with antiphospholipid antibodies. Proceedings of the Second International Symposium on Antiphospholipid Antibodies (1986) 3-10
19. Brucato A., Baudo F., Barberis M., Redaelli R., Casadei G., Allegri F., et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J. Rheumatol. 21 (1994) 942-944
20. Cacoub P., Dorent R., Nataf P., Carayon A., Riquet M., Noe E., et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc. Res. 33 (1997) 196-200
21. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., and Camps M.T. Antiphospholipid Syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 Patients. Arthritis Rheum. 46 (2002) 1019-1027 This multicenter study describes the prevalence of the main clinical and immunologic features of 1000 APS patients at disease onset and during the evolution
22. Chaouat A., Weitzenblum E., and Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur. Respir. J. 9 (1996) 356-363
23. Colorio C.C., Martinuzzo M.E., Forastiero R.R., Pombo G., Adamczuk Y., and Carreras L.O. Thrombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul. Fibrinol. 12 (2001) 427-432
24. Crausman R.S., Achenbach G.A., Pluss W.T., O'Brien R.F., and Jennings C.A. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J. Rheumatol. 22 (1995) 554-556
25. Crowther M.A., Ginsberg J.S., Julian J., Math J.M., Denburg J., Hirsh J., et al. A Comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 349 (2003) 1133-1138
26. Cucurull E., Ordi-Ros J., Murtra M., Mellibovsky L., Orriols R., and Vilardell M. Pulmonary thromboendarterectomy in a patient with primary antiphospholipid syndrome. Med. Clin. (Barc.) 106 (1996) 498-500
27. Day S.M., Rosenzweig B.P., and Kronzon I. Transesophageal echocardiographic diagnosis of right atrial thrombi associated with the antiphospholipid syndrome. J. Am. Soc. Echocardiogr. 8 (1995) 937-940
28. De la Mata J., Gomez-Sanchez M.A., Aranzana M., and Gomez-Reino J.J. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum. 37 (1994) 1528-1533
29. Espinosa G., Cervera R., Font J., and Asherson R.A. The lung in the antiphospholipid syndrome. Ann. Rheum. Dis. 61 (2002) 195-198
30. Font J., Cervera R., López-Soto A., Pallarés L., Bosch X., Ampurdanés S., et al. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin. Rheumatol. 8 (1989) 475-483
31. Font J., López-Soto A., Cervera R., Balasch J., Pallarés L., Navarro M., et al. The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 9 (1991) 69-75
32. Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of the disease and treatment. J. Rheumatol. 26 (1999) 805-807 This study describes the clinical manifestations, laboratory findings, and treatment of 5 patients with the APS who develop diffuse alveolar hemorrhage
33. Gertner E., and Lie J.T. Pulmonary capillaritis, alveolar haemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J. Rheumatol. 20 (1993) 1224-1228
34. Ghosh S., Walters H.D., Joist J.H., Osborn T.G., and Moore T.L. Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J. Rheumatol. 20 (1993) 1406-1408
35. Greaves M., Cohen H., Machin S.J., and Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br. J. Hematol. 109 (2000) 704-715
36. Haworth S.G. Primary pulmonary hypertension. J. R. Coll. Physicians Lond. 32 (1998) 187-190
37. Hillerdal G. The lung physician and the antiphospholipid syndrome. Eur. Respir. J. 10 (1997) 511-512
38. Hillerdal G., Hagg A., Licke G., Wegenius G., and Scheibenpflug L. Intra-alveolar hemorrhage in the anticardiolipin antibody syndrome. Scand. J. Rheumatol. 20 (1991) 58-62
39. Howe H.S., Boey M.L., Fong K.Y., and Feng P.H. Pulmonary hemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann. Rheum. Dis. 47 (1988) 869-872
40. Humbert M., Sanchez O., Fartoukh M., Jagot J.L., Sitbon O., and Simmonneau G. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest 114 Suppl. 1 (1998) 80-82
41. Hussein A., Trowitzsch E., and Brockmann M. Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent. Klin. Padiatr. 211 (1999) 92-95
42. Ingram S.B., Goodnight S.H., and Bennett R.M. An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies. Arthritis Rheum. 30 (1987) 37-42
43. Jamieson S.W., Auger W.R., Fedullo P.F., Channick R.N., Kriett J.M., Tarazi R.Y., et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J. Thorac. Cardiovasc. Surg. 106 (1993) 116-127
44. Jeffrey P., Asherson R.A., and Rees P.J. Recurrent deep venous thrombosis and thromboembolic pulmonary hypertension in the 'primary' antiphospholipid syndrome. Clin. Exp. Rheumatol. 7 (1989) 567-569
45. Karmochkine M., Cacoub P., Dorent R., Laroche P., Nataf P., Piette J.C., et al. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J. Rheumatol. 23 (1996) 286-290
46. Kelion A.D., Cockcroft J.R., and Ritter J.M. Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad. Med. J. 71 (1995) 233-235
47. Kerr J.E., Poe R., and Kramer Z. Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 112 (1997) 1707-1710
48. Khamashta M.A., Cuadrado M.J., Mujic F., Taub N.A., Hunt B.J., and Hughes G.R.V. The management of thrombosis in the antiphospholipid-antibody syndrome. N. Engl. J. Med. 332 (1995) 993-997
49. Krnic-Barrie S., O'Connor C.R., Looney S.W., Pierangeli S.S., and Harris E.N. A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis. Arch. Intern. Med. 157 (1997) 2101-2108 These two studies suggest that oral anticoagulant treatment in APS patients with venous thromboembolism should be carried on longer than in aPL-negative patients with DVT or PE
50. Kupferminc M.J., Lee M.J., Green D., and Peaceman A.M. Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies. Obstet. Gynecol. 83 (1994) 806-807
51. Levine J.S., Branch W., and Rauch J. The antiphospholipid syndrome. N. Engl. J. Med. 346 (2003) 752-763 This is an extensive review of the various clinical manifestations and management of APS
52. Libby L., King T., Laforce F.M., and Schwarz M.I. Pulmonary cavitation following pulmonary infarction. Medicine 64 (1985) 342-348
53. Luchi M.E., Asherson R.A., and Lahita R.G. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum. 35 (1992) 700-705
54. Mackworth-Young C.G., Gharavi A.E., Boey M.L., and Hughes G.R.V. Portal and pulmonary hypertension in a case of systemic lupus erythematosus: possible relationship with clotting abnormalities. Eur. J. Rheumatol. Inflamm. 7 (1984) 71-74
55. Maggiorini M., Knoblauch A., Schneider J., and Russi E.W. Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome. Eur. Respir. J. 10 (1997) 727-730
56. Magro C.M., Pope-Harman A., Moh P., and Ross Jr. P. Primary antiphospholipid antibody syndrome caused by isolated anti-phosphatidylethanolamine antibodies presenting as cryptogenic fibrosing alveolitis with recurrent pulmonary hemorrhage after single-lung transplantation. J. Heart Lung Transplant 21 (2001) 1232-1236
57. McCarty G.A. Vascular pathology of the antiphospholipid antibody syndrome. In: Khamashta M.A. (Ed). Hughes Syndrome. The Antiphospholipid Syndrome (2000), Springer, London 263-280
58. Mintz G., Acevedo-Vazquez E., Gutierrez-Espinosa G., and Avelar-Garnica F. Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Arthritis Rheum. 27 (1984) 539-544
59. Miyata M., Suzuki K., Sakuma F., Watanabe H., Kaise S., Nishimaki T., et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int. Arch. Allergy Immunol. 100 (1993) 351-354
60. Moser K.M., Auger W.R., and Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 81 (1990) 1735-1743
61. Muñoz-Rodri{dotless}́guez F.J., Font J., Cervera R., Reverter J.C., Tàssies D., Espinosa G., et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin. Arthritis Rheum. 29 (1999) 182-190
62. Nagai H., Yasuma K., Katsuki T., Shimakura A., Usuda K., Nakamura Y., et al. Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report. Angiology 48 (1997) 183-187
63. Nakagawa Y., Masuda M., Shiihara H., Tsuruta Y., Abe H., Miura M., et al. Succesful pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension associated with anticardiolipin antibodies: report of a case. Surg. Today 22 (1992) 548-552
64. Nakos G., Kitsiouli E., Maneta-Peyret L., Cassagne C., Tsianos E., and Lekka M. The characteristics of bronchoalveolar lavage from a patient with antiphospholipid syndrome who developed acute respiratory distress syndrome. Clin. Rheumatol. 20 (2001) 91-97
65. O'Hickey S., Skinner C., and Beattie J. Life-threatening right ventricular thrombosis in association with phospholipid antibodies. Br. Heart. J. 70 (1993) 279-281
66. Petri M., Rheinschmidt M., Whiting-O'Keefe Q., Hellmann D., and Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann. Intern. Med. 106 (1987) 524-531
67. Piette J.C., and Hunt B.J. Pulmonary hypertension and antiphospholipid antibodies. In: Khamashta M.A. (Ed). Hughes Syndrome. The Antiphospholipid Syndrome (2000), Springer, London 96-104 The authors review the expanding knowledge of the pathogenic disease pathways of pulmonary hypertension in APS
68. Rana M., Endo H., Watabe H., Tanaka S., and Kondo H. A case of primary antiphospholipid syndrome complicated with pulmonary hypertension. Ryumachi 41 (2001) 869-874
69. Rich S., Kaufmann E., and Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327 (1992) 76-81
70. Rosove M.H., and Brewer P.M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann. Intern. Med. 117 (1992) 303-308
71. Ruiz-Irastorza G., Khamashta M.A., Hunt B.J., Escudero A., Cuadrado M.J., and Hughes G.R. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch. Intern. Med. 162 (2002) 1164-1169
72. Sandoval J., Amigo M.C., Barragan R., Izaguirre R., Reyes P.A., Marti{dotless}́nez-Guerra M.L., et al. Primary antiphospholipid syndrome presenting as chronic thromboembolic hypertension. Treatment with thromboendarterectomy. J. Rheumatol. 23 (1996) 772-775
73. Savin H., Hoberman M., Kott E., Lishner M., Kitai Y., Kidron D., et al. Fibrosing alveolitis associated with primary antiphospholipid antibodies. J. Rheumatol. 33 (1994) 977-980
74. Specks U. Diffuse alveolar hemorrhage syndromes. Curr. Opin. Rheumatol. 13 (2001) 12-17
75. Tam L.-S., and Li E.K. Succesful treatment with immunosupression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome. Lupus 7 (1998) 495-497
76. Turjanski A.A., Finkielman J.D., and Vazquez-Blanco M. Isolated tricuspid valve disease in antiphospholipid syndrome. Lupus 8 (1998) 474-476
77. Vianna J.L., Khamashta M.A., Ordi-Ros J., Font J., Cervera R., López-Soto A., et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am. J. Med. 96 (1994) 3-9
78. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 (2000) 1334-1349
79. Waterer G.W., Latham B., Waring J.A., and Gabbay E. Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis. Respirology 4 (1999) 405-408
80. Wiedermann F.J., Lederer W., Mayr A.J., Sepp N., Herold M., and Schobersberger W. Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: comparison with catastrophic antiphospholipid syndrome. Lupus 12 (2003) 462-467
81. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.-C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42 (1999) 1309-1311
82. Wolf M., Boyer-Neumann C., Parent F., Eschwege V., Jaillet H., Meyer D., et al. Thrombotic risk factors in pulmonary hypertension. Eur. Respir. J. 15 (2000) 395-399